低分子肝素钙抗凝治疗短暂性脑缺血发作的疗效观察

Efficacy of Low molecular weight heparin anticoagulation for recurrent TIA

目的探讨低分子肝素钙抗凝治疗短暂性脑缺血发作(transient ischemic attack,TIA)的疗效。方法将102例患者随机分为治疗组与对照组,对照组仅采用调整血压、抑制血小板凝集、活血化瘀、改善脑组织代谢等治疗措施;治疗组加用低分子肝素钙抗凝治疗,疗效均7d。结果两组治疗后治疗组TIA 3d、7d症状消失率明显高于对照组,1个月内TIA发作例数明显少于对照组(P<0.05)。结论低分子肝素对TIA的抗凝治疗有效、安全、可行。

Objective To explore the low molecular weight heparin anticoagulation efficacy of recurrent TIA. Methods Totally 102 patients were randomly divided into treatment group and control group,control group,only by adjusting the blood pressure,inhibit platelet aggregation,blood circulation,improve metabolism of brain tissue treatment;treatment group were treated with low molecular weight heparin anticoagulant therapy,effects were 7d. Results After treatment,the treatment group TIA3d,7d symptoms was significantly higher in one month,the number of cases was less with the TIA episodes than the control group（P〈0.05）. Conclusions The low molecular weight heparin on the TIA,anticoagulant therapy effective,safe and feasible.